News of Ixazomib

On November 20, 2015, the U.S. Food and Drug Administration (FDA) approved Ninlaro (ixazomib) for the treatment of multiple myeloma.

The U.S. FDA Grants Priority Review Status to Takeda’s Ixazomib for the Treatment of Relapsed/Refrac

On September 9, 2015, Cambridge, Massachusetts, USA, and Osaka, Japan, announced···【more】
Release date：2026-01-07Recommended：313
The U.S. Food and Drug Administration (FDA) has approved ixazomib for the treatment of multiple myel

The U.S. Food and Drug Administration (FDA) approved ixazomib today for use in c···【more】
Release date：2026-01-07Recommended：318

Your Health, We Care